Practice
  • Home
  • News
  • Pin Points
  • Events
  • Programmes
  • Resources
  • About
REFINE YOUR SEARCH
FILTERS
CLEAR FILTERS
Region
Category
Target age
Programmes » Aclasta (Zoledronic acid infusions) Lakes

Aclasta (Zoledronic acid infusions) Lakes

Lakes | Under 18 | Over 18 | Over 65

This programme provides funding for Aclasta infusions for eligible patients

The infusion is to be provided in the community by the patient’s general practice.  

Your Pinnacle Services Contract applies to this service. By claiming for this service, you have indicated that you have read and agreed to the business rules set out here.   

This is NOT a clinical guideline.  

Details

Which practices can claim for this service?

All Pinnacle practices in Te Whatu Ora Lakes region can claim for this service. 

Who is eligible for the service?

Patients who are Māori, Pacific, a CSC holder or are Quintile 5 and who meet the special authority criteria (SA1780) for the administration of zoledronic acid.  

Patients domiciled in Te Whatu Ora Lakes area.

Who is excluded from the service?
  • Patients not enrolled in a Te Whatu Ora Lakes general practice.  
  • Patients not domiciled in Te Whatu Ora Lakes area.
When is the service complete?
  • The episode of care ends when the outcome and claim are submitted. 
  • Payment will be made once an outcome has been lodged for the case. 
  • Each infusion will require a new claim. 
Claiming guidelines

Please make your claim via Primary Options, select Aclasta Infusion and then attach the appropriate invoice(s).

Aclasta: $150 (including GST)  

Please be aware the claim is all inclusive of the GP consult, the administration of the infusion, observation time and consumables.  

This service does not include the cost of the medication on special authority, this is the responsibility of the patient to purchase. 

The dosing and frequency of administration varies, in accordance with the indication for use. Each administration will require a new claim. 

What level of clinical notes do I need to submit?

Practices are required to provide sufficiently detailed consultation notes to determine appropriate use of funding.  

It has been recommended that in addition to a good assessment and history, the eligibility criteria are clearly stated in the clinical notes.  

Does the patient have to pay?

A patient co-payment cannot be charged.

This service does not include the cost of the medication on special authority, this is the responsibility of the patient to purchase.

How is the service funded?

The service is funded by Te Whatu Ora.

Contact

Primary options team, Pinnacle Midlands Health Network
infoprimaryoptions@pinnacle.health.nz
027 687 7312

YOU MAY ALSO BE INTERESTED IN
NEWS
Insights from PowerBI: Melatonin use
Jo Scott-Jones | 23/06/2021

An occasional series illustrating the value of using PowerBI to explore your own data. This issue focuses on 'off label' use of melatonin.

Read more
Medication
RESOURCE
Clinical Zoom meeting snippets - September 2023
Published: 04/10/2023

Dr Jo Scott-Jones and Dr Dave Maplesden discuss assessing capacity (in activating enduring power of attorney), HPV screening, changes to opioid prescribing and more.

View resource
Taranaki
47 Molesworth Street
New Plymouth 4310
+64 6 759 4364
Tairāwhiti
Level 1
295-299 Gladstone Road (entrance via Cobden Street)
Gisborne 4010
PO Box 1188
Gisborne 4040
06 863 2661
Lakes
Level 1
95 Te Heuheu Street
Taupō 3330
PO Box 1716
Taupō 3351
+64 7 376 0060
Waikato
Norris Ward McKinnon House
Level 3
711 Victoria Street
Hamilton 3204
PO Box 983
Hamilton 3240
+64 7 839 2888
Facebook @PinnacleIncorporated LinkedIn midlands-health-network
Copyright © 2025 Pinnacle Incorporated
Privacy policy Terms & conditions Practice update dashboard
Copyright © 2025 Pinnacle Incorporated
Privacy policy Terms & conditions Practice update dashboard